1. Left Superior Vena Cava Persistence in Patients Undergoing Pacemaker or Cardioverter-Defibrillator Implantation
- Author
-
L. Frabetti, Mauro Biffi, Giuseppe Boriani, Angelo Branzi, and Gabriele Bronzetti
- Subjects
Pulmonary and Respiratory Medicine ,Tachycardia ,medicine.medical_specialty ,education.field_of_study ,business.industry ,Population ,Critical Care and Intensive Care Medicine ,medicine.disease ,Ventricular tachycardia ,law.invention ,Surgery ,Catheter ,law ,Superior vena cava ,medicine ,Artificial cardiac pacemaker ,Persistent left superior vena cava ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,education ,business ,Prospective cohort study - Abstract
Objective The persistence of a left superior vena cava(LSVC) has been observed in 0.3% of the general population asestablished by autopsy. In the adult population, it is an importantanatomic finding if a left superior approach to the heart isconsidered. The aim of the study was to evaluate the prevalence of aLSVC in patients undergoing pacemaker (PM) andcardioverter-defibrillator (CD) implantation. Design We observed the prevalence of LSVC during a 10-year period; eachpatient undergoing PM or transvenous CD implantation received a leftcephalic/left subclavian venous approach to the heart. With thistechnique, LSVC persistence is easily diagnosed during leadplacement. Results A total of 1,139 patientsconsecutively underwent PM implantation during 10 years: 4 patients hadpersistent LSCV (0.34%). Among 115 patients undergoing CDimplantation, 2 patients with LSVC (1.7%) were observed. Overall LSVCpersistence was found in 6 of 1,254 patients (0.47%). Two patients, one of whom had no right superior vena cava (RSVC), received aleft-sided PM, whereas two other patients received right-sided devices. Both CD patients received a left-sided active-can device: the firstpatient with a right-sided lead tunneled to the left pectoral pocket, as a result of poor catheter handling through the LSVC and coronarysinus, and the second patient with a screw-in lead from LSVC. Long-termfollow-up of these patients (average ± SD, 41 ± 26 months)revealed absence of lead dislodgment and appropriate device functionregardless of lead implantation site. Conclusions Persistence of LSVC in adults undergoing PM/CD implantation is similarto that of the general population (0.47% in our study). The left-sidedimplant can be achieved by stylet shaping and by use of active fixationleads in most patients, with a reliable outcome at short term inaddition to appropriate device performance at follow-up. Assessment ofthe RSVC is advisable when planning a right-sided implantation, since aminority of patients lacks this vessel.
- Published
- 2001